薬剤比較
Semaglutide vs Repaglinide
Semaglutide vs Repaglinide for T2D: GLP-1 agonist vs meglitinide. Compare A1c, weight loss, CV benefits vs postprandial control and hypo risk.
このページには比較できる項目がありません。
臨床的背景
This comparison is relevant when choosing oral agents for type 2 diabetes, especially oral GLP-1 (Rybelsus) versus a mealtime meglitinide in patients needing postprandial coverage.
結論
Semaglutide is generally preferred for broader metabolic and CV benefits, while Repaglinide suits flexible mealtime dosing with functioning beta cells.
すべての薬剤比較